Further Support for Early-Life Allergen Exposure

Egg and peanut consumption during infancy is linked to lower risk of allergy to those foods later in life, according to a meta-analysis.

Written byJef Akst
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, MR.ATOZAnalyzing data from 146 studies involving more than 200,000 children, researchers from Imperial College London have found additional evidence for the recent hypothesis that exposing young children to certain foods might reduce their risk of allergies to those foods. Specifically, the authors of this UK Food Standards Agency–commissioned meta-analysis found that babies fed eggs and peanuts had lower risk of egg and peanut allergies as children. On the other hand, the researchers did not find sufficient support for a similar conclusion regarding milk, fish (including shellfish), nuts, and wheat. The results, published today (September 20) in JAMA, support the growing realization that recommendations to delay babies’ exposure to some allergenic foods may be harmful.

“This study . . . is more evidence shedding light on the fact that early introduction in the right children can prevent allergies,” Purvi Parikh, an allergist at New York University Langone Medical Center who was not involved in the present study, told New York Daily News.

“The rigorous, comprehensive meta-analysis . . . is an important addition to the evidence regarding food allergy prevention,” Matthew Greenhawt of Children’s Hospital Colorado wrote in an accompanying editorial. “Their conclusions highlight that the 2008 guidelines to not delay introduction were correct.”

In February 2015, an international team of researchers found that infants at high risk of peanut allergies were less likely to develop the allergy if they were exposed to the food early on. Last year, a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies